KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Elanco Animal Health (ELAN) EBITDA Margin (2017 - 2025)

Elanco Animal Health (ELAN) has disclosed EBITDA Margin for 9 consecutive years, with 13.81% as the latest value for Q4 2025.

  • Quarterly EBITDA Margin rose 6793.0% to 13.81% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 16.86% through Dec 2025, up 5099.0% year-over-year, with the annual reading at 16.86% for FY2025, 5099.0% up from the prior year.
  • EBITDA Margin hit 13.81% in Q4 2025 for Elanco Animal Health, down from 14.69% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 20.87% in Q1 2025 to a low of 148.31% in Q3 2023.
  • Historically, EBITDA Margin has averaged 38.27% across 5 years, with a median of 46.52% in 2023.
  • Biggest five-year swings in EBITDA Margin: tumbled -9802bps in 2023 and later soared 15482bps in 2024.
  • Year by year, EBITDA Margin stood at 57.1% in 2021, then increased by 5bps to 54.52% in 2022, then dropped by -14bps to 62.13% in 2023, then increased by 13bps to 54.12% in 2024, then surged by 126bps to 13.81% in 2025.
  • Business Quant data shows EBITDA Margin for ELAN at 13.81% in Q4 2025, 14.69% in Q3 2025, and 17.81% in Q2 2025.